-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GMIs7pOAp/42sxHisyjWTXYZAp3pugapaim7NDxk1in1nga28Z/tUXHIQmGSWMdC kQdcjOol960uB87fXTpcug== 0001193125-10-007839.txt : 20100308 0001193125-10-007839.hdr.sgml : 20100308 20100119105346 ACCESSION NUMBER: 0001193125-10-007839 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellu Tissue Holdings, Inc. CENTRAL INDEX KEY: 0001295976 STANDARD INDUSTRIAL CLASSIFICATION: PAPER MILLS [2621] IRS NUMBER: 061346495 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: (678)393-2651 MAIL ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 CORRESP 1 filename1.htm Acceleration Request

[Cellu Tissue Holdings, Inc. Letterhead]

January 19, 2010

VIA FACSIMILE AND EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Mail Stop 3561

100 F Street, NE

Washington, DC 20549-3561

Attention: Damon Colbert

 

  Re: Cellu Tissue Holdings, Inc.
       Registration Statement on Form S-1
       File No. 333-162543

Dear Mr. Colbert:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cellu Tissue Holdings, Inc. (the “Company”), hereby requests acceleration of the effective date of the Registration Statement on Form S-1 (No. 333-162543) to 1:00 p.m., Washington, D.C. time, on Thursday, January 21, 2010, or as soon thereafter as practicable.

In addition, the Company acknowledges that:

 

   

should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

   

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

   

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.


Securities and Exchange Commission

January 19, 2010

Page 2

Please call the undersigned at (770) 407-2169 or Tracy Kimmel of King & Spalding LLP at (212) 556-2294 if you have any questions.

 

Sincerely,

Cellu Tissue Holdings, Inc.

By:

 

/s/ W. Edwin Litton

 

W. Edwin Litton

  General Counsel, Senior Vice
  President, Human Resources and
  Secretary

 

cc: Tracy Kimmel
     King & Spalding LLP
-----END PRIVACY-ENHANCED MESSAGE-----